NEW YORK (GenomeWeb) – Private investment firms Ampersand Capital Partners and 1315 Capital announced today that they have partnered with a management group to acquire the commercial laboratory of Novartis subsidiary Genoptix.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.